Multivalent DNA Flowers for High-Performance Isolation, Detection, and Release of Tumor-Derived Extracellular Vesicles
Source abstract
Abstract
Tumor-derived extracellular vesicles (T-EVs) hold great promise for understanding cancer biology and improving cancer diagnostics and therapeutics. Herein, we developed multivalent DNA flowers (DFs) containing repeated and equidistant EpCAM aptamers for the efficient isolation of T-EVs. The multivalent aptamer chains in DFs had good flexibility to adapt to the surface morphology of T-EVs and achieved multivalent ligand–receptor interactions, thus showing enhanced isolation ability compared to monovalent aptamers. Compared with other materials for isolation of EVs, DFs were generated by rolling circle amplification (RCA) and self-assembled into microspheres in a one-pot reaction, and the recognition molecules (aptamers) were directly replicated and assembled during the RCA reaction instead of chemical modification and immobilization on the surface of solid materials. Moreover, as optically transparent biomaterials, the content of EpCAM + EVs could be directly reflected via membrane-based hydrophobic assembly of signaling modules in DFs@EpCAM + EVs complex, and we found that the amount of EpCAM + EVs showed greater accuracy in cancer diagnosis than total EVs (88.3 vs 69.7%) and was also higher than the clinically commonly used marker carcinoembryonic antigen (CEA) (88.3 vs 76.7%). In addition, T-EVs could be released by lysis of DFs with the nuclease, gently and easily, keeping high intact and activity of EVs for downstream biological function studies. These results demonstrated that DFs are efficient and nondestructive tools for isolation, detection, and release of T-EVs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Zhejiang University, Hangzhou 310058, China
The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
GeneX (Zhejiang) Precision Medicine Co., Ltd, Hangzhou 311100, China
Department of Oncology, PKUCare Luzhong Hospital, Zibo, Shandong 255499, China
Funding
National Natural Science Foundation of China
References (47)
Show source-provided references
1. 10.1126/science.aau697710.1126/science.aau6977 ↗
2. 10.1038/nri85510.1038/nri855 ↗
3. 10.1038/ncb159610.1038/ncb1596 ↗
4. 10.3389/fimmu.2022.81794210.3389/fimmu.2022.817942 ↗
5. 10.1016/j.bbcan.2020.18848810.1016/j.bbcan.2020.188488 ↗
6. 10.1038/s41586-018-0392-810.1038/s41586-018-0392-8 ↗
7. 10.1038/nature1458110.1038/nature14581 ↗
8. 10.18632/oncotarget.1038410.18632/oncotarget.10384 ↗
9. 10.1038/s41569-018-0110-010.1038/s41569-018-0110-0 ↗
10. 10.1016/j.nano.2015.01.00310.1016/j.nano.2015.01.003 ↗
11. 10.1021/acs.analchem.8b0303110.1021/acs.analchem.8b03031 ↗
12. 10.1016/j.chroma.2014.10.02610.1016/j.chroma.2014.10.026 ↗
13. 10.3402/jev.v5.3082910.3402/jev.v5.30829 ↗
14. 10.1039/C6AN00892E10.1039/C6AN00892E ↗
15. 10.3402/jev.v3.2343010.3402/jev.v3.23430 ↗
16. 10.1016/j.ymeth.2015.05.02810.1016/j.ymeth.2015.05.028 ↗
17. 10.1002/anie.20200597410.1002/anie.202005974 ↗
18. 10.1021/jacs.9b1378210.1021/jacs.9b13782 ↗
19. 10.1016/j.ygyno.2008.04.03310.1016/j.ygyno.2008.04.033 ↗
20. 10.1002/anie.20221533710.1002/anie.202215337 ↗
21. 10.1002/anie.20201562810.1002/anie.202015628 ↗
22. 10.1002/adfm.20200323710.1002/adfm.202003237 ↗
23. 10.1021/acs.chemrev.0c0114010.1021/acs.chemrev.0c01140 ↗
24. 10.1002/jev2.1228110.1002/jev2.12281 ↗
25. 10.1021/acs.analchem.2c0372510.1021/acs.analchem.2c03725 ↗
26. 10.1021/ar400195t10.1021/ar400195t ↗
27. 10.1002/anie.20180933710.1002/anie.201809337 ↗
28. 10.1038/nnano.2013.20510.1038/nnano.2013.205 ↗
29. 10.1021/acs.nanolett.2c0337710.1021/acs.nanolett.2c03377 ↗
30. 10.1038/s41596-022-00791-710.1038/s41596-022-00791-7 ↗
31. 10.1002/adfm.20221340110.1002/adfm.202213401 ↗
32. 10.1021/acsnano.3c0210210.1021/acsnano.3c02102 ↗
33. 10.1021/nn501596210.1021/nn5015962 ↗
34. 10.1002/anie.20221150510.1002/anie.202211505 ↗
35. 10.1038/nbt.169210.1038/nbt.1692 ↗
36. 10.1021/acsami.6b0821010.1021/acsami.6b08210 ↗
37. 10.1021/jacs.9b1101510.1021/jacs.9b11015 ↗
38. 10.1038/nprot.2015.07810.1038/nprot.2015.078 ↗
39. 10.1021/acs.analchem.0c0430810.1021/acs.analchem.0c04308 ↗
40. 10.1002/adma.20200773810.1002/adma.202007738 ↗
41. 10.1038/srep0755610.1038/srep07556 ↗
42. 10.1016/j.tcb.2009.06.00410.1016/j.tcb.2009.06.004 ↗
43. 10.1021/acs.analchem.2c0383910.1021/acs.analchem.2c03839 ↗
44. 10.1002/smll.20220814210.1002/smll.202208142 ↗
45. 10.1021/acssensors.2c0281910.1021/acssensors.2c02819 ↗
46. 10.1021/acs.analchem.2c0372710.1021/acs.analchem.2c03727 ↗
47. 10.1021/acsnano.1c0642910.1021/acsnano.1c06429 ↗